Niagen Bioscience, Inc. · NASDAQ:NAGE
The Vanguard Group's stake in Niagen Bioscience, Inc. fell to 4.11% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group's stake in Niagen Bioscience, Inc. fell to 4.11%, 3,286,498 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 4.11%
- Shares
- 3,286,498
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.11% | 3,286,498 |
Source
Related
- Niagen Bioscience, Inc.
- The Vanguard Group
- Niagen Bioscience, Inc. shareholders
- Schedule 13G · The Vanguard Group · Oct 31, 2025
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Lopez Carlos Luis · Jul 8, 2026
- Form 4 · Pamir Ozan · Jul 8, 2026
- Form 4 · Fried Robert N · Jul 8, 2026
- Form 4 · Fried Robert N · Apr 27, 2026